With 20 years of experience in MNCs and investment sector. Previously held the positions of Business Development Director, China Head, Investment VP and Managing Director at:
MNCs such as A.T.Kkearney, SHELL, General Electric, Philips, and Syngenta
CXC Capital, Managing Director ($200 million fund)
GL Capital, Senior VP ($450 million fund)
Olympus Capital, China Head ($1 billion fund)
Investment Sample Cases before bioVENTURE:
Pharmaron (CRO), BGI (Already exit by selling old share)
Kangchen Pharma (exited), Gan-Lee Pharma, Jingfeng Pharma (IPO)
Arrail Dental, Zhejiang Kangning Hospital (IPO)
HC SemiTek (Listed company code: 300323)
MBA from Cornell University (US); Bachelor from Zhongshan University
MSc in Organic Chemistry from Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences; BSc in Pharmaceutical Engineering from China Pharmaceutical University.
Previous work experience includes Nanjing Baojun Capital as Analyst, and Basilea (China) as medicinal chemist.